Jesse Pustjens - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Jesse Pustjens

Showing results (11-20 of 15) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 15 results.

Liver International : Official Journal of the International Association for the Study of the Liver|July 7, 2026

Urinary Volatile Organic Compound Metabolites Are Associated With MASLD/MASH in Humans and Induce Steatosis in Liver OrganoidsLaurens A van Kleef, Xincheng Li, Pengfei Li, et al.

JHEP Reports : Innovation in Hepatology|March 20, 2026

Underuse of statins in MASLD despite population-based associations with lower liver stiffnessJesse Pustjens, Laurens A van Kleef, Jelena Pavlović, et al.

Gastroenterology|June 15, 2026

Validated early detection metrics reduce the population requiring liver fibrosis screeningLaurens A van Kleef, Jesse Pustjens, Carolin V Schneider, et al.

The Lancet. Gastroenterology & Hepatology|June 2, 2026

Liver stiffness dynamics in European populations (LiverScreen): a longitudinal, multicentre, prospective, population-based cohort studyJesse Pustjens, Katrine Tholstrup Bech, Guillem Pera, et al.

Lancet (London, England)|April 13, 2026

Prevalence of liver fibrosis in the general population (the LiverScreen project): a multinational European cohort studyIsabel Graupera, Maja Thiele, Laurent Castera, et al.

Pageof 2

Search research articles

Showing results (11-20 of 15) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 15 results.

Liver International : Official Journal of the International Association for the Study of the Liver|July 7, 2026

Urinary Volatile Organic Compound Metabolites Are Associated With MASLD/MASH in Humans and Induce Steatosis in Liver OrganoidsLaurens A van Kleef, Xincheng Li, Pengfei Li, et al.

JHEP Reports : Innovation in Hepatology|March 20, 2026

Underuse of statins in MASLD despite population-based associations with lower liver stiffnessJesse Pustjens, Laurens A van Kleef, Jelena Pavlović, et al.

Gastroenterology|June 15, 2026

Validated early detection metrics reduce the population requiring liver fibrosis screeningLaurens A van Kleef, Jesse Pustjens, Carolin V Schneider, et al.

The Lancet. Gastroenterology & Hepatology|June 2, 2026

Liver stiffness dynamics in European populations (LiverScreen): a longitudinal, multicentre, prospective, population-based cohort studyJesse Pustjens, Katrine Tholstrup Bech, Guillem Pera, et al.

Lancet (London, England)|April 13, 2026

Prevalence of liver fibrosis in the general population (the LiverScreen project): a multinational European cohort studyIsabel Graupera, Maja Thiele, Laurent Castera, et al.

Pageof 2